Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Debt / NOTE 1.500% 6/1
-
Number of holders
-
24
-
Total 13F principal, excl. options
-
172,661,287
-
Principal change
-
-18,648,713
-
Total reported value, excl. options
-
$175,938,133
-
Value change
-
-$19,057,125
-
Number of buys
-
7
-
Number of sells
-
6
-
Price
-
$1.02
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 as of Q3 2022
As of 30 Sep 2022 IRONWOOD PHARMACEUTICALS INC - NOTE 1.500% 6/1 had 24 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $172,661,287 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included CITADEL ADVISORS LLC, CAMDEN ASSET MANAGEMENT L P /CA, CAPSTONE INVESTMENT ADVISORS, LLC, WOLVERINE ASSET MANAGEMENT LLC, CALAMOS ADVISORS LLC, PUTNAM INVESTMENTS LLC, Polar Asset Management Partners Inc., SSI INVESTMENT MANAGEMENT LLC, AQR Arbitrage LLC, and SHENKMAN CAPITAL MANAGEMENT INC.
This table shows 24 bond principal holders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.